CI-1040

DRUG2 trials

Sponsors

University of Alabama at Birmingham, Pfizer

Conditions

Breast CancerBreast NeoplasmsCarcinoma, Non-Small-Cell LungColorectal CancerColorectal NeoplasmsLung CancerPancreatic CancerPancreatic Neoplasms

Phase 2

A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer

CompletedNCT00034827

PfizerBreast Neoplasms, Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms +1

Start: 2002-01-31End: 2003-05-31Target: 172Updated: 2007-05-04

CI-1040 in Treating Patients With Advanced Breast, Colon, Pancreatic, or Non-Small Cell Lung Cancer

CompletedNCT00033384

University of Alabama at BirminghamBreast Cancer, Colorectal Cancer, Lung Cancer +1

Start: 2002-02-28End: 2003-11-30Updated: 2013-04-12